These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 1898894)
1. Adjusting the dose to the individual response of the patient during the induction of ovulation with pulsatile gonadotropin-releasing hormone. Mais V; Melis GB; Strigini F; Antinori D; de Ruggiero A; Fioretti P Fertil Steril; 1991 Jan; 55(1):80-5. PubMed ID: 1898894 [TBL] [Abstract][Full Text] [Related]
2. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders. Filicori M; Flamigni C; Meriggiola MC; Ferrari P; Michelacci L; Campaniello E; Valdiserri A; Cognigni G J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487 [TBL] [Abstract][Full Text] [Related]
3. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management. Filicori M; Flamigni C; Campaniello E; Valdiserri A; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216 [TBL] [Abstract][Full Text] [Related]
4. Polycystic ovary syndrome: abnormalities and management with pulsatile gonadotropin-releasing hormone and gonadotropin-releasing hormone analogs. Filicori M; Flamigni C; Campaniello E; Meriggiola MC; Michelacci L; Valdiserri A; Ferrari P Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 2):1737-42. PubMed ID: 2122730 [TBL] [Abstract][Full Text] [Related]
5. Ovulation induction with subcutaneous pulsatile gonadotropin-releasing hormone in various ovulatory disorders. Saffan D; Seibel MM Fertil Steril; 1986 Apr; 45(4):475-82. PubMed ID: 3082681 [TBL] [Abstract][Full Text] [Related]
6. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH. Filicori M; Campaniello E; Michelacci L; Pareschi A; Ferrari P; Bolelli G; Flamigni C J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511 [TBL] [Abstract][Full Text] [Related]
7. Combined use of gonadotropin-releasing hormone and its analogues for ovulation induction optimization. Filicori M Clin Obstet Gynecol; 1993 Sep; 36(3):737-43. PubMed ID: 8403620 [No Abstract] [Full Text] [Related]
8. Endocrinology of gonadotropin-releasing hormone induced cycles in hypothalamic amenorrhea: the role of the pulse dose. Braat DD; Schoemaker J Fertil Steril; 1991 Dec; 56(6):1054-9. PubMed ID: 1743321 [TBL] [Abstract][Full Text] [Related]
9. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome. Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835 [TBL] [Abstract][Full Text] [Related]
11. Ovulation induction with pulsatile luteinizing releasing hormone in women with clomiphene citrate-resistant polycystic ovary-like disease: clinical results. Burger CW; Korsen TJ; Hompes PG; van Kessel H; Schoemaker J Fertil Steril; 1986 Dec; 46(6):1045-54. PubMed ID: 3096792 [TBL] [Abstract][Full Text] [Related]
12. Evidence for a specific role of GnRH pulse frequency in the control of the human menstrual cycle. Filicori M; Flamigni C; Campaniello E; Ferrari P; Meriggiola MC; Michelacci L; Pareschi A; Valdiserri A Am J Physiol; 1989 Dec; 257(6 Pt 1):E930-6. PubMed ID: 2514600 [TBL] [Abstract][Full Text] [Related]
13. Use of combined exogenous gonadotropins and pulsatile gonadotropin-releasing hormone in patients with polycystic ovarian disease: a new approach to induction of ovulation. Venturini PL; Remorgida V; Anserini P; De Cecco L Gynecol Endocrinol; 1988 Sep; 2(3):205-13. PubMed ID: 3147583 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of intravenous pulsatile gonadotropin-releasing hormone: Lutrepulse for injection. Santoro N Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 2):1759-64. PubMed ID: 2122733 [TBL] [Abstract][Full Text] [Related]
15. [Induction of ovulation with pulsatile LHRH in anovulatory women]. Masaoka K; Kumasaka T Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jun; 36(6):937-46. PubMed ID: 6431037 [TBL] [Abstract][Full Text] [Related]
16. Does polycystic ovarian morphology influence the response to treatment with pulsatile GnRH in functional hypothalamic amenorrhea? Dumont A; Dewailly D; Plouvier P; Catteau-Jonard S; Robin G Reprod Biol Endocrinol; 2016 Apr; 14(1):24. PubMed ID: 27129705 [TBL] [Abstract][Full Text] [Related]
17. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea. Couzinet B; Young J; Brailly S; Chanson P; Schaison G J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262 [TBL] [Abstract][Full Text] [Related]
19. Exaggerated free alpha-subunit levels during pulsatile gonadotropin-releasing hormone replacement in women with idiopathic hypogonadotropic hypogonadism. Lavoie HB; Martin KA; Taylor E; Crowley WF; Hall JE J Clin Endocrinol Metab; 1998 Jan; 83(1):241-7. PubMed ID: 9435449 [TBL] [Abstract][Full Text] [Related]
20. Pulsatile administration of low-dose gonadotropin-releasing hormone. Ovulation and pregnancy in women with hypothalamic amenorrhea. Miller DS; Reid RR; Cetel NS; Rebar RW; Yen SS JAMA; 1983 Dec; 250(21):2937-41. PubMed ID: 6417355 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]